Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection

F Gallais, P Gantner, T Bruel, A Velay, D Planas… - …, 2021 - thelancet.com
Background Assessment of the kinetics of SARS-CoV-2 antibodies is essential in predicting
risk of reinfection and durability of vaccine protection. Methods This is a prospective …

Anti-SARS-CoV-2 antibodies persist for up to 13 months and reduce risk of reinfection

F Gallais, P Gantner, T Bruel, A Velay, D Planas… - Medrxiv, 2021 - medrxiv.org
Assessment of the kinetics of SARS-CoV-2 antibodies is essential in predicting protection
against reinfection and durability of vaccine protection. Here, we longitudinally measured …

Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection

EHY Lau, DSC Hui, OTY Tsang, WH Chan… - …, 2021 - thelancet.com
Background The duration of immunity in SARS-CoV-2 infected people remains unclear.
Neutralizing antibody responses are the best available correlate of protection against re …

Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study

A Leidi, F Koegler, R Dumont, R Dubos, ME Zaballa… - MedRxiv, 2021 - medrxiv.org
Importance Serological assays detecting specific IgG antibodies generated against the
Spike protein following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) …

[HTML][HTML] Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection

C Gerhards, M Thiaucourt, M Kittel, C Becker… - International Journal of …, 2021 - Elsevier
Introduction The longevity of antibody levels against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and the duration of immunity are current topics of major …

SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma …

E Terpos, D Stellas, M Rosati, TN Sergentanis… - European journal of …, 2021 - Elsevier
Elucidating the characteristics of human immune response against SARS-CoV-2 is of high
priority and relevant for determining vaccine strategies. We report the results of a follow-up …

[HTML][HTML] Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study

A Atti, F Insalata, EJ Carr, AD Otter, J Castillo-Olivares… - Journal of Infection, 2022 - Elsevier
Objectives To investigate serological differences between SARS-CoV-2 reinfection cases
and contemporary controls, to identify antibody correlates of protection against reinfection …

The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers

SF Lumley, J Wei, D O'Donnell, NE Stoesser… - MedRxiv, 2020 - medrxiv.org
Abstract Background SARS-CoV-2 IgG antibody measurements can be used to estimate the
proportion of a population exposed or infected and may be informative about the risk of …

Longitudinal serological analysis and neutralizing antibody levels in coronavirus disease 2019 convalescent patients

F Muecksch, H Wise, B Batchelor… - The Journal of …, 2021 - academic.oup.com
Background Understanding the longitudinal trajectory of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibodies is crucial for diagnosis of prior infection and …

Long-term kinetics of SARS-CoV-2 antibodies and impact of inactivated vaccine on SARS-CoV-2 antibodies based on a COVID-19 patients cohort

S Zhang, K Xu, C Li, L Zhou, X Kong, J Peng… - Frontiers in …, 2022 - frontiersin.org
Background Understanding the long-term kinetic characteristics of SARS-CoV-2 antibodies
and the impact of inactivated vaccines on SARS-CoV-2 antibodies in convalescent patients …